We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Point72 Asset Management
126
Point72 Asset Management
Connecticut
$5.25M +$4.93M +35,798 +2,983%
UBS Group
127
UBS Group
Switzerland
$5.24M +$639K +4,642 +14%
RBA
128
Richard Bernstein Advisors
New York
$4.62M – – –
Capital Fund Management (CFM)
129
Capital Fund Management (CFM)
France
$4.55M +$27.5K +200 +0.6%
WT
130
Whittier Trust
California
$4.29M +$44.7K +325 +1%
OPERF
131
Oregon Public Employees Retirement Fund
Oregon
$4.28M +$24.9K +181 +0.6%
CAM
132
ClariVest Asset Management
California
$4.2M +$4.08M +29,600 New
RA
133
Royce & Associates
New York
$4.11M – – –
Marshall Wace
134
Marshall Wace
United Kingdom
$4.08M +$3.96M +28,751 New
VOYA Investment Management
135
VOYA Investment Management
Georgia
$3.98M +$93.6K +680 +2%
Pacer Advisors
136
Pacer Advisors
Pennsylvania
$3.9M -$291K -2,117 -7%
US Bancorp
137
US Bancorp
Minnesota
$3.85M +$45K +327 +1%
QIM
138
Quest Investment Management
Oregon
$3.74M -$117K -850 -3%
TAM
139
Trillium Asset Management
Massachusetts
$3.67M +$518K +3,762 +17%
ARTA
140
A.R.T. Advisors
New York
$3.63M +$179K +1,300 +5%
N
141
Natixis
France
$3.58M -$4.92M -35,703 -59%
MLICM
142
Metropolitan Life Insurance Company (MetLife)
New York
$3.31M +$203K +1,472 +7%
CB
143
Commerce Bank
Missouri
$3.21M +$2.45M +17,790 +364%
BNP Paribas Financial Markets
144
BNP Paribas Financial Markets
France
$3.12M +$1.24M +9,001 +69%
SOMRS
145
State of Michigan Retirement System
Michigan
$3.04M -$55.1K -400 -2%
SAM
146
Security Asset Management
New York
$3.02M – – –
NMIMC
147
Northwestern Mutual Investment Management Company
Wisconsin
$2.98M +$9.64K +70 +0.3%
PP
148
Paloma Partners
Connecticut
$2.98M +$644K +4,678 +29%
BC
149
Brinker Capital
Pennsylvania
$2.97M -$234K -1,701 -8%
AIP
150
Ameritas Investment Partners
Nebraska
$2.96M -$73.7K -535 -3%
4 5
6
7 8

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.